Home / Recalls / American Health Packaging / D-0020-2022

D-0020-2022 Class II Terminated

Recalled by American Health Packaging — Columbus, OH

Recall Details

Product Type
Drugs
Report Date
October 27, 2021
Initiation Date
September 17, 2021
Termination Date
June 8, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,266 cartons

Product Description

GlipiZIDE Extended-Release Tablets, 2.5 mg, 30 Tablets (3 blister cards each with 10 individually blistered doses), Rx only, Manufactured by: Patheon Pharmaceuticals Inc., Cincinnati, OH 45237; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054. Carton NDC#: 68084-295-21 (Individual Dose NDC: 68084-295-11)

Reason for Recall

Failed Dissolution Specifications: results were above specification.

Distribution Pattern

Nationwide within the USA

Code Information

Lot #: 194141, Exp. Date 03/31/2022

Other recalls by American Health Packaging

  • D-0880-2022 Class III — Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals), 100 mg, 100 Capsules ( (May 3, 2022)
  • D-0790-2022 Class III — Cyanocobalamin Injection, USP, 1000 mcg per mL, For Intramuscular or Subcutaneou (April 12, 2022)
  • D-0652-2022 Class II — Oxycodone Hydrochloride Oral Solution, USP (C-II), 5 mg/5 mL, Delivers 5 mL per (February 22, 2022)
  • D-0451-2022 Class II — Metoprolol Succinate Extended-Release Tablets, USP 50 mg, 500-count bottle, Rx O (December 20, 2021)
  • D-0854-2021 Class II — Valproic Acid Oral Solution, USP, 500 mg/10 mL, 100 10 mL unit dose cups per cas (September 15, 2021)
  • D-0813-2021 Class III — Sirolimus Tablets 1 mg, 30 Tablets (5 blister cards x 6 unit doses), Rx only, Pa (May 12, 2021)
  • D-0232-2021 Class II — Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals), 100 mg, 100 per carton (January 7, 2021)
  • D-1372-2020 Class III — Nabumetone Tablets, USP, 500 mg, 100 Tablets per carton (10 tablets x 10 blister (June 10, 2020)
  • D-1293-2020 Class II — Doxycycline Hyclate Tablets, USP, 100 mg, 30 Tablets per carton (3 x 10), Rx onl (May 19, 2020)
  • D-0849-2020 Class II — Desmopressin Acetate Tablets, 0.2 mg, 30 tablets (3 x 10 unit dose blister cards (February 7, 2020)